The effect of exercise on cognitive function in people with multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials
G Li, Q You, X Hou, S Zhang, L Du, Y Lv, L Yu - Journal of neurology, 2023 - Springer
Objective A growing body of research examining the effect of exercise on cognitive function
in people with multiple sclerosis (MS), while findings of available studies were conflicting …
in people with multiple sclerosis (MS), while findings of available studies were conflicting …
The role of nutritional lifestyle and physical activity in multiple sclerosis pathogenesis and management: a narrative review
S Fanara, M Aprile, S Iacono, G Schirò, A Bianchi… - Nutrients, 2021 - mdpi.com
Studies on the role of nutritional factors and physical activity (PA) in the pathogenesis of
multiple sclerosis (MS) go back a long time. Despite the intrinsic difficulty of studying their …
multiple sclerosis (MS) go back a long time. Despite the intrinsic difficulty of studying their …
Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms
M Langeskov‐Christensen, LG Hvid… - Acta Neurologica …, 2022 - Wiley Online Library
Objectives Fatigue and walking impairment are disabling symptoms of multiple sclerosis
(MS). We investigated the effects of progressive aerobic exercise (PAE) on fatigue, walking …
(MS). We investigated the effects of progressive aerobic exercise (PAE) on fatigue, walking …
Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: a randomized controlled trial
Background Multiple sclerosis (MS) is a chronic progressive neurodegenerative disease of
the central nervous system. Although there is increasing evidence that aerobic exercise has …
the central nervous system. Although there is increasing evidence that aerobic exercise has …
[HTML][HTML] Systematic review of cognitive reserve in multiple sclerosis: Accounting for physical disability, fatigue, depression, and anxiety
C Stein, F O'Keeffe, O Strahan, C McGuigan… - Multiple Sclerosis and …, 2023 - Elsevier
Background Cognitive reserve (CR) describes an individual's ability to adapt cognitive
processes in response to brain atrophy, and has been reported to explain some of the …
processes in response to brain atrophy, and has been reported to explain some of the …
Exercise therapy in early multiple sclerosis improves physical function but not cognition: Secondary analyses from a randomized controlled trial
M Riemenschneider, LG Hvid… - … and Neural Repair, 2023 - journals.sagepub.com
Background Exercise positively affects multiple sclerosis (MS) symptoms, physiological
systems, and potentially cognition. However, an uninvestigated “window of opportunity” …
systems, and potentially cognition. However, an uninvestigated “window of opportunity” …
Effects of walking exercise training on learning and memory and hippocampal neuroimaging outcomes in MS: a targeted, pilot randomized controlled trial
BM Sandroff, GR Wylie, JF Baird, CD Jones… - Contemporary Clinical …, 2021 - Elsevier
Purpose The current pilot study involved a single-blind, randomized controlled trial (RCT) on
the effects of treadmill walking exercise training compared with an active control condition …
the effects of treadmill walking exercise training compared with an active control condition …
Use of pragmatic randomized trials in multiple sclerosis: A systematic overview
Background: Pragmatic trials are increasingly recognized for providing real-world evidence
on treatment choices. Objective: The objective of this study is to investigate the use and …
on treatment choices. Objective: The objective of this study is to investigate the use and …
Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal
AJ Thompson, W Carroll, O Ciccarelli… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: Progressive forms of multiple sclerosis (MS) affect more than 1 million
individuals globally. Recent approvals of ocrelizumab for primary progressive MS and …
individuals globally. Recent approvals of ocrelizumab for primary progressive MS and …
Non-Pharmacological Treatments of Cognitive Impairment in Multiple Sclerosis: A Review
M Bossa, N Manocchio, O Argento - NeuroSci, 2022 - mdpi.com
Cognitive impairment (CI) represents a common symptom in patients suffering from multiple
sclerosis (MS), which can affect every stage of the disease course. Recent studies seem to …
sclerosis (MS), which can affect every stage of the disease course. Recent studies seem to …